Crossref
journal-article
Oxford University Press (OUP)
Human Molecular Genetics (286)
References
42
Referenced
38
10.1038/ng0298-164
/ Nat. Genet / Short GCG expansions in the PABP2 gene cause oculopharyngeal muscular dystrophy by Brais (1998)10.1016/j.bbadis.2006.10.003
/ Biochim. Biophys. Acta / Oculopharyngeal muscular dystrophy: recent advances in the understanding of the molecular pathogenic mechanisms and treatment strategies by Abu-Baker (2007)10.1016/j.biocel.2006.01.016
/ Int. J. Biochem. Cell Biol / Oculopharyngeal muscular dystrophy: potential therapies for an aggregate-associated disorder by Davies (2006)10.1093/oxfordjournals.hmg.a018924
/ Hum. Mol. Genet / Nuclear inclusions in oculopharyngeal muscular dystrophy consist of poly(A) binding protein 2 aggregates which sequester poly(A) RNA by Calado (2000)10.1016/S0960-8966(97)00085-0
/ Neuromuscul. Disord / Morphological changes in muscle fibers in oculopharyngeal muscular dystrophy by Tome (1997)10.1002/1097-4598(200010)23:10<1549::AID-MUS11>3.0.CO;2-0
/ Muscle Nerve / Nuclear accumulation of expanded PABP2 gene product in oculopharyngeal muscular dystrophy by Uyama (2000)10.1038/nm1242
/ Nat. Med / Doxycycline attenuates and delays toxicity of the oculopharyngeal muscular dystrophy mutation in transgenic mice by Davies (2005)10.1074/jbc.M109633200
/ J. Biol. Chem / Mammalian, yeast, bacterial, and chemical chaperones reduce aggregate formation and death in a cell model of oculopharyngeal muscular dystrophy by Bao (2002)10.1136/jmg.2003.014548
/ J. Med. Genet / Congo red, doxycycline, and HSP70 overexpression reduce aggregate formation and cell death in cell models of oculopharyngeal muscular dystrophy by Bao (2004)10.1093/hmg/ddi331
/ Hum. Mol. Genet / Lithium rescues toxicity of aggregate-prone proteins in Drosophila by perturbing Wnt pathway by Berger (2005)10.1038/sj.emboj.7601117
/ Embo J / A Drosophila model of oculopharyngeal muscular dystrophy reveals intrinsic toxicity of PABPN1 by Chartier (2006)10.1016/j.bbaexp.2004.03.008
/ Biochim. Biophys. Acta / Structure and function of poly(A) binding proteins by Kuhn (2004)10.1017/S1355838200991908
/ RNA / Deciphering the cellular pathway for transport of poly(A)-binding protein II by Calado (2000)10.1016/j.devcel.2005.09.002
/ Dev. Cell / An essential cytoplasmic function for the nuclear poly(A) binding protein, PABP2, in poly(A) tail length control and early development in Drosophila by Benoit (2005)10.1093/hmg/10.21.2341
/ Hum. Mol. Genet / Oligomerization of polyalanine expanded PABPN1 facilitates nuclear protein aggregation that is associated with cell death by Fan (2001)10.1038/sj.embor.7400795
/ EMBO Rep / Human inhibitor of apoptosis proteins: why XIAP is the black sheep of the family by Eckelman (2006)10.1016/S0278-5846(03)00017-4
/ Prog. Neuropsychopharmacol. Biol. Psychiatry / Natural cellular inhibitors of caspases by LeBlanc (2003)10.1523/JNEUROSCI.20-24-09126.2000
/ J. Neurosci / Protection by synergistic effects of adenovirus-mediated X-chromosome-linked inhibitor of apoptosis and glial cell line-derived neurotrophic factor gene transfer in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease by Eberhardt (2000)10.1038/sj.gt.3302683
/ Gene Ther / XIAP-mediated neuroprotection in retinal ischemia by Renwick (2006)10.1038/sj.gt.3302927
/ Gene Ther / X-chromosome linked inhibitor of apoptosis protein inhibits muscle proteolysis in insulin-deficient mice by Wang (2007)10.1158/1535-7163.MCT-06-0426
/ Mol. Cancer Ther / Mithramycin A sensitizes cancer cells to TRAIL-mediated apoptosis by down-regulation of XIAP gene promoter through Sp1 sites by Lee (2006)10.1084/jem.188.1.211
/ J. Exp. Med / Nuclear factor (NF)-kappaB-regulated X-chromosome-linked iap gene expression protects endothelial cells from tumor necrosis factor alpha-induced apoptosis by Stehlik (1998)10.1038/11109
/ Nat. Cell. Biol / A new internal-ribosome-entry-site motif potentiates XIAP-mediated cytoprotection by Holcik (1999)10.1126/science.288.5467.874
/ Science / Ubiquitin protein ligase activity of IAPs and their degradation in proteasomes in response to apoptotic stimuli by Yang (2000)10.1006/geno.1997.4742
/ Genomics / Genomic organization and primary characterization of miap-3: the murine homologue of human X-linked IAP by Farahani (1997)10.1006/geno.2001.6635
/ Genomics / Genomic organization of the X-linked inhibitor of apoptosis and identification of a novel testis-specific transcript by Lagace (2001)10.1261/rna.5225204
/ RNA / Demonstrating internal ribosome entry sites in eukaryotic mRNAs using stringent RNA test procedures by Van Eden (2004)10.1016/S0378-1119(03)00774-1
/ Gene / Alternative ways to think about mRNA sequences and proteins that appear to promote internal initiation of translation by Kozak (2003)10.1128/MCB.16.11.6573
/ Mol. Cell Biol / Translational control of programmed cell death: eukaryotic translation initiation factor 4E blocks apoptosis in growth-factor-restricted fibroblasts with physiologically expressed or deregulated Myc by Polunovsky (1996)10.1128/MCB.22.8.2853-2861.2002
/ Mol. Cell Biol / Translational control of cell fate: availability of phosphorylation sites on translational repressor 4E-BP1 governs its proapoptotic potency by Li (2002)10.1053/j.gastro.2004.09.002
/ Gastroenterology / Translational regulation of XIAP expression and cell survival during hypoxia in human cholangiocarcinoma by Marienfeld (2004)10.1158/0008-5472.CAN-05-2447
/ Cancer Res / Mechanism by which mammalian target of rapamycin inhibitors sensitize multiple myeloma cells to dexamethasone-induced apoptosis by Yan (2006)10.1016/j.molmed.2006.04.003
/ Trends Mol. Med / The role of apoptosis in neuromuscular diseases and prospects for anti-apoptosis therapy by Miller (2006)10.1016/S0960-8966(02)00030-5
/ Neuromuscul. Disord / Apoptosis and muscle fibre loss in neuromuscular disorders by Tews (2002)10.1038/ng1270
/ Nat. Genet / Mitochondrial dysfunction and apoptosis in myopathic mice with collagen VI deficiency by Irwin (2003)10.1242/jcs.00806
/ J. Cell Sci / A caveolin-3 mutant that causes limb girdle muscular dystrophy type 1C disrupts Src localization and activity and induces apoptosis in skeletal myotubes by Smythe (2003)10.1242/jcs.108.6.2197
/ J. Cell Sci / Apoptosis precedes necrosis of dystrophin-deficient muscle by Tidball (1995){'key': 'key\n\t\t\t\t20170522143040_DDM382C38', 'first-page': '1005', 'article-title': 'Apoptotic myonuclei in human Duchenne muscular dystrophy', 'volume': '78', 'author': 'Sandri', 'year': '1998', 'journal-title': 'Lab. Invest'}
/ Lab. Invest / Apoptotic myonuclei in human Duchenne muscular dystrophy by Sandri (1998)10.1093/hmg/ddi095
/ Hum. Mol. Genet / Muscle-specific BCL2 expression ameliorates muscle disease in laminin {alpha}2-deficient, but not in dystrophin-deficient, mice by Dominov (2005)10.1172/JCI22928
/ J. Clin. Invest / Inhibition of apoptosis improves outcome in a model of congenital muscular dystrophy by Girgenrath (2004)10.1093/hmg/ddh017
/ Hum. Mol. Genet / Myopathy phenotype in transgenic mice expressing mutated PABPN1 as a model of oculopharyngeal muscular dystrophy by Hino (2004)10.1083/jcb.139.5.1281
/ J. Cell Biol / Movement of Bax from the cytosol to mitochondria during apoptosis by Wolter (1997)
Dates
Type | When |
---|---|
Created | 17 years, 7 months ago (Jan. 4, 2008, 8:25 p.m.) |
Deposited | 3 years, 11 months ago (Aug. 31, 2021, 10:11 p.m.) |
Indexed | 1 month ago (July 30, 2025, 10:52 a.m.) |
Issued | 17 years, 7 months ago (Jan. 4, 2008) |
Published | 17 years, 7 months ago (Jan. 4, 2008) |
Published Online | 17 years, 7 months ago (Jan. 4, 2008) |
Published Print | 17 years, 4 months ago (April 15, 2008) |
@article{Davies_2008, title={Wild-type PABPN1 is anti-apoptotic and reduces toxicity of the oculopharyngeal muscular dystrophy mutation}, volume={17}, ISSN={0964-6906}, url={http://dx.doi.org/10.1093/hmg/ddm382}, DOI={10.1093/hmg/ddm382}, number={8}, journal={Human Molecular Genetics}, publisher={Oxford University Press (OUP)}, author={Davies, Janet E. and Sarkar, Sovan and Rubinsztein, David C.}, year={2008}, month=jan, pages={1097–1108} }